Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05KEF
|
||||
Former ID |
DNC007132
|
||||
Drug Name |
LUF-5978
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528673] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H21N3
|
||||
Canonical SMILES |
CC(C)CC1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4
|
||||
InChI |
1S/C22H21N3/c1-15(2)13-20-24-21-18(16-9-5-3-6-10-16)14-19(23-22(21)25-20)17-11-7-4-8-12-17/h3-12,14-15H,13H2,1-2H3,(H,23,24,25)
|
||||
InChIKey |
PPFWSQNEFCXMGP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [528673] | |
Adenosine A2b receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A3 receptor | Target Info | Inhibitor | [528673] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.